‘Should we stop or continue conventional synthetic (including glucocorticoids) and targeted DMARDs before surgery in patients with inflammatory rheumatic diseases?’

Total hip and total knee arthroplasty) remain important interventions to treat symptomatic knee and hip damage in patients with rheumatoid arthritis, with little change in utilisation rates despite the increasingly widespread use of potent conventional synthetic disease-modifying anti-rheumatic drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodman, Susan M, George, Michael D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722271/
https://www.ncbi.nlm.nih.gov/pubmed/32719151
http://dx.doi.org/10.1136/rmdopen-2020-001214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722271/
https://www.ncbi.nlm.nih.gov/pubmed/32719151
http://dx.doi.org/10.1136/rmdopen-2020-001214

Ejemplares similares